Tuesday, April 30, 2019

Diasome: Father-Son Developing Nanotech to Improve Insulin Effectiveness

Diasome Pharmaceuticals, run by a father-son team in Ohio, is developing a nanotech compound that would make insulin work better in the liver.

From https://www.healthline.com/diabetesmine/diasome-liver-insulin-therapy



from
https://healthnews010.wordpress.com/2019/04/30/diasome-father-son-developing-nanotech-to-improve-insulin-effectiveness/

from https://karlfletcher.blogspot.com/2019/04/diasome-father-son-developing-nanotech.html

from
https://karlfletcher1.tumblr.com/post/184549717203

No comments:

Post a Comment